Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.

Journal of human genetics - 1 Jan 2007

Troudi Wafa, Uhrhammer N, Sibille C, Dahan C, Mahfoudh W, Bouchlaka Souissi C, Jalabert T, Chouchane L, Bignon Y J, Ben Ayed F, Ben Ammar Elgaaied A

Abstract excerpt

Hereditary breast cancer accounts for 3-8% of all breast cancers, with mutations in the BRCA1 and BRCA2 genes responsible for up to 30% of these. To investigate the prevalence of BRCA1 and BRCA2 gene mutations in breast cancer patients with affected relatives in Tunisia, we studied 36 patients who had at least one first degree relative with breast and/or ovarian cancer Thirty-four 34 patients were suggestive of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to BRCA1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mutation

Share to Tunisia

Source

Identifiers

PMID: 17922257
DOI: 10.1007/s10038-007-0195-5

Genes

BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.PMID 17922257Read ↗

Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.Semantic proximity Read ↗

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.Semantic proximity Read ↗

Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.Semantic proximity Read ↗

Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related CancersSemantic proximity Read ↗

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.Semantic proximity Read ↗

Contribution of BRCA1 5382insC mutation in triple negative breast cancer in TunisiaSemantic proximity Read ↗

Novel and Recurrent BRCA1/BRCA2 Germline Mutations in Patients with Breast /Ovarian Cancer: A Series from the South of TunisiaSemantic proximity Read ↗

Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in LebanonSemantic proximity Read ↗

Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North AfricaSemantic proximity Read ↗

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.Semantic proximity Read ↗

Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.Semantic proximity Read ↗

A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.